Notable Labs Ltd 's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Notable Labs Ltd 's ROA in the second quarter of 2024?
Notable Labs Ltd recorded a cumulative net loss of $-24 million during 12 months ending in the second quarter of 2024, resulting in a negative return on assets (ROA) of -64.69%.

However, within the Healthcare sector 920 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2024 from 4760 to 4809.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Total Assets Change	-59.19 %	-53.5 %	263.85 %	-39.02 %	-41.04 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-24	-22	-24	-12	-22
Return On Assets (TTM)	-64.69 %	-54.45 %	-55.49 %	-46.76 %	-76.84 %
NTBL's Total Ranking	# 4809	# 4760	# 5487	# 4607	# 4990
Total Assets (TTM) in million	10	13	103	21	25
Seq. Total Assets Change	-23.42 %	-87.28 %	391.36 %	-14.7 %	-12.74 %
Seq. Net Income Change	-	-	-	-	-

NTBL's 5 Years Annual ROA >> Back to NTBL Management Effectiveness >> Compare NTBL ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 440
Sector	# 921
Overall	# 4724

Return On Assets Statistics
High	Average	Low
52.29 %	-59.53 %	-141.69 %
(Dec 31 2020)		(Jun 30 2024)

Financial Statements
Notable Labs Ltd 's Assets	$ 10 million	NTBL's Balance sheet
Notable Labs Ltd 's Income	$ -5 million	Quarterly NTBL's Income Statement
NTBL's Income by Division		See NTBL's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	263.85 %	-58.11 %	-25.18 %	-29.44 %	-2.12 %
Total Assets in million	103	28	67	90	128
Y / Y Net Income Change	-	7.97 %	23.51 %	-	-
Net Income in million	-11	32	30	24	0
Annual Return On Assets	-10.95 %	114.24 %	44.33 %	26.85 %	0 %

NTBL's 5 Years Annual ROA >> Back to NTBL Management Effectiveness >> Compare NTBL ROA to its Competitors

More Return On Assets Ratios
NTBL's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NTBL's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NTBL's Competitors
Subscribers only: Roa for Notable Labs Ltd 's Suppliers
Subscribers only: Return On Assets for NTBL's Customers

You may also want to know
NTBL's Roi	NTBL's Inventory Turnover Ratio	NTBL's Growth Rates	NTBL's Dividend Comparisons
	NTBL's Profitability Ratios	NTBL's Asset Turnover Ratio	NTBL's Dividend Growth
NTBL's Roe	NTBL's Valuation Ratios	NTBL's Financial Strength Ratios	NTBL's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.